Swiss Federal Institute of Technology
ethz.chTotal trials
152
Active
8
Phase 3
0
Total enrollment
31,553
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Iron Deficiency25
- Iron-deficiency24
- Iron Deficiency Anemia14
- Iodine Deficiency9
- Anemia8
- Healthy8
- Zinc Deficiency6
- Stroke5
Frequently asked questions about Swiss Federal Institute of Technology
- How many clinical trials does Swiss Federal Institute of Technology have on ClinicalTrials.gov?
- Swiss Federal Institute of Technology is listed as the lead sponsor on 152 clinical trials in ClinicalTrials.gov, 8 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Swiss Federal Institute of Technology's trials are in Phase 3?
- 0 of Swiss Federal Institute of Technology's trials are in Phase 3.
- What therapeutic areas does Swiss Federal Institute of Technology focus on?
- Swiss Federal Institute of Technology's most-studied conditions on ClinicalTrials.gov are Iron Deficiency, Iron-deficiency, Iron Deficiency Anemia, Iodine Deficiency, Anemia.